DOST: 3K to join COVID vaccine mix and match trial
The Department of Science and Technology (DOST) announced that 3,000 people will participate in clinical trials to study the safety and efficacy of mixing different COVID-19 vaccine brands.
Each arm of the trial will have between 250 to 500 participants receiving various combinations such as Sinovac-Janssen and Sinovac-Moderna.
The pilot tests for these 'mix and match' trials are scheduled in Marikina, Muntinlupa, and Davao cities with dry runs already conducted or planned.
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.